Skip to content

十亿分一

US · BLLN #2109 按市值排名 上市于 2025
98.12 -4.61 -4.49%
实时 - 追踪5344个代码 - 心跳于76秒前 · 2026-10-16 20:01

✦ 量化股权信号 计算方式说明

减持
  • 最近一期（2026/Q3）披露持股的机构数量减少了1家。
  • 机构持股总比例下降了6.2个百分点。

机构持股

机构持股比例
64.25% -6.17pp
机构数量
185 -1
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

VC/PE Fund30.63%
Mutual Fund25.55%
Individual/Insider10.56%
Private Company4.65%
Hedge Fund2.26%
Public Company0.54%
Government Pension Fund0.43%
Family Office/Trust0.10%
Other25.19%

主要股东 截至 2025-11-07

Hummingbird Ventures Management NV 16.71% · 7.89M 股
Libertus Capital Limited 7.55% · 3.56M 股
Oguzhan Atay 4.98% · 2.35M 股
David Tsao 4.89% · 2.31M 股
Wipro Enterprises Private Limited 3.78% · 1.78M 股
Adams Street Partners, LLC 3.63% · 1.71M 股
NeoTribe Ventures 2.45% · 1.15M 股
T. Rowe Price Group, Inc. 2.34% · 1.10M 股
Baillie Gifford 1.91% · 901.42K 股
Vanguard Capital Management, LLC 1.79% · 842.34K 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 7次买入 · 43次卖出

姓名职务持股比例
Hummingbird Ventures Management NV -- 16.71%
Oguzhan Atay Chairperson & CEO 4.98%
David Tsao Co-Founder, President, CTO & Director 4.89%
Shan Sakakibara Chief Product Officer 0.42%
Krishna Kolluri Independent Director 0.07%
Firat Ileri Lead Independent Director 0.06%
John Bosch Senior Vice President of Laboratory Operations 0.05%
Nancy Johnson Senior Vice President of Sales & Commercial Operations 0.01%
Akshay Rai Independent Director 0.01%
Thomas Lynch Chief Compliance Officer, General Counsel & Secretary 0.00%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-10-04 David Tsao Co-Founder, President, CTO & Director Intent to Sell (Form 144) -20,000 $108.15
2026-10-04 David Tsao Co-Founder, President, CTO & Director Intent to Sell (Form 144) -1,750 $105.15
2026-10-04 John Bosch Senior Vice President of Laboratory Operations Intent to Sell (Form 144) -2,834 $105.15
2026-09-27 Oguzhan Atay Chairperson & CEO Automatic Disposition -2,666 $120.64
2026-09-27 Oguzhan Atay Chairperson & CEO Derivative Exercise and Sale -8,333 $2.80–120.64
2026-09-23 David Tsao Co-Founder, President, CTO & Director Derivative Exercise and Sale -3,333 $2.80–125.00
2026-09-23 John Bosch Senior Vice President of Laboratory Operations Automatic Disposition -1,416 $120.00
2026-09-20 John Bosch Senior Vice President of Laboratory Operations Automatic Disposition -1,416 $106.61
2026-09-16 Thomas Lynch Chief Compliance Officer, General Counsel & Secretary Derivative Exercise and Sale -35,112 $8.65–110.36
2026-09-13 Oguzhan Atay Chairperson & CEO Automatic Disposition -5,332 $98.00
2026-09-13 Oguzhan Atay Chairperson & CEO Derivative Exercise and Sale -24,999 $2.80–101.49
2026-09-09 Shan Sakakibara Chief Product Officer Other Disposition -3,500 --
2026-09-08 Oguzhan Atay Chairperson & CEO Derivative Exercise and Sale -20,000 --
2026-09-08 David Tsao Co-Founder, President, CTO & Director Derivative Exercise and Sale -20,000 $2.80–100.00
2026-09-08 John Bosch Senior Vice President of Laboratory Operations Automatic Disposition -1,416 $97.54
2026-09-07 Thomas Lynch Chief Compliance Officer, General Counsel & Secretary Derivative Exercise and Sale -20,000 $8.65–101.41
2026-09-07 David Tsao Co-Founder, President, CTO & Director Derivative Exercise and Sale -20,000 --
2026-08-25 NeoTribe Ventures -- Other Acquisition +48,491 --
2026-08-25 NeoTribe Ventures -- Other Disposition -484,442 --
2026-08-24 David Tsao Co-Founder, President, CTO & Director Derivative Exercise and Sale -10,000 $2.80–100.00

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 20:01:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

十亿分一 讨论区 0 条评论

发表评论